Coronavirus update Profile picture
May 30, 2021 4 tweets 1 min read Read on X
Who should NOT get Pfizer or Johnson vaccine?

According to CDC: If you are allergic to

☆polyethylene glycol (PEG), you should NOT get either of the mRNA COVID-19 vaccines (Moderna or Pfizer).

☆polysorbate, you should not get the Johnson & Johnson vaccine.

1/
If you are allergic to other types of vaccines, for example, the flu shot, you should consult your doctor before scheduling a COVID-19 vaccine.

2/End
CDC recommendations for people with a previous history of allergic reactions👇👇👇

cdc.gov/coronavirus/20…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Coronavirus update

Coronavirus update Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @BitaScicomm

Sep 4, 2021
Kidney outcomes in LongCovid
Bowe et al., 2019

What's #LongCovid?

it's scientifically proved that COVID-19 is not death or survival. The disease is associated with increased risk of post-acute sequelae involving pulmonary and extrapulmonary organ systems called #longCOVID.
1/
Q: What was the aim of this study?

Scientists wanted to evaluate the detailed assessment of kidney outcomes in long COVID.
2/
What did scientists do?From Mar 2020-Mar2021 they built a cohort of:
Total: 1,726,683 people
☆89,216 were 30-day COVID-19 survivors
☆1,637,467 non-infected controls
They examined risks of decline in kidney fuction&major adverse kidney events(decline in kidney function≥50%)
Read 12 tweets
Aug 26, 2021
Lets unpack this study.

Morbidity and mortality from COVID-19 post-vaccination breakthrough infections in
association with various COVID-19 vaccines and the emergence of variants in the Kingdom of Bahrain.

AlQahtani et al., 2021

1/
We know that:

1. Vaccines were designed against the original variants

2. The virus is keep mutating

3. Breakthrough infections occur.

4. Vaccines protects against severe illness& death

So, they are Critical questions that needs to be asked.

2/
Q: What was the aim of this study?

1.What is the effectiveness of various vaccines in
preventing infection, symptomatic disease, hospitalization,ICU admission&death

2.What are the clinical consequences of post-vaccination infections in the context of
emerging variants
3/
Read 11 tweets
Jul 28, 2021
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner:

What was the aim of this study?

To evaluate the effect of prior Covid-19 infection on Ad26.COV2.S immunogenicity approximately 28 days post-vaccination.
1/
What does immunigenicity mean 🤔?

Immunogenucity= how well a vaccine works+ measures the type of immune responses that the vaccine generates over time
2/
What did researchers do?

They compared:
A: healthcare workers (HCWs) without previous history of covid19 infection

B: HCWs infected during the first wave prior to the emergence of Beta

C: HCWs infected in the second wave, when Beta was the dominant variant.
3/
Read 7 tweets
Jul 28, 2021
The study investigated 6 Month Safety and Efficacy of the Pfizer Vaccine:

How?

A total of ~47,000 including 44,165 ≥16-year-old participants& 2,264 12-15-year-old participants were randomized to receive 2 doses, 21 days apart, of 30 μg vaccine or placebo.
1/
What do they report here?

Study endpoints reported here are vaccine efficacy (VE) against laboratory-confirmed COVID-19 and safety data, both up to 6 months post-vaccination.
2/
What did they find?

☆Pfizer vaccine continued to be safe and well tolerated.

☆VE against COVID-19 was 91% through up to 6 months of follow-up
☆VE of 86%‒100% was seen across countries and in populations with diverse characteristics of age,
3/
Read 7 tweets
Jul 28, 2021
#Covid19vaccines

This work aim at evaluating the immunogenicity of the Sinopharm, antibody responses against different SARS-CoV-2 variants of concern in individuals in Sri Lanka.
1/
What did they do?

They measured the SARS-CoV-2-specific antibodies (abs) in 282 individuals 2 weeks after 2d dose.

2/
Some technical details😉 on what they measured.

sero - at baseline,& ACE2 receptor blocking abs, abs to the RBD of the wild type (WT), B.1.1.7, B.1.351 and B.1.617.2, ex vivo&
cultured IFNγ ELISpot assays, intracellular cytokine secretion assays and B cell ELISpot assays.
3/
Read 10 tweets
Jul 27, 2021
#Getvaccinated

#COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors

☆Up to 20%–30% of patients hospitalized with COVID-19 have evidence of myocardial involvement.

1/
☆Acute cardiac injury in patients hospitalized with COVID19 is associated with higher morbidity&mortality.

☆Myocarditis from viralpathogens can evolve into overt or subclinical myocardial dysfunction, and cause death.This raises concerns 4 patients recovering from COVID-19.
2/
☆Some patients will have subclinical and possibly overt cardiovascular abnormalities.

☆Patients with ostensibly recovered cardiac function may still be at risk of cardiomyopathy and cardiac arrhythmias.
3/
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(